Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study

Eur Respir J. 2020 Oct 15;56(4):2001935. doi: 10.1183/13993003.01935-2020. Print 2020 Oct.

Abstract

Helmet CPAP treatment fails in up to 44% of patients with moderate-to-severe hypoxaemic acute respiratory failure due to COVID-19 pneumonia https://bit.ly/3g7FAB8

Publication types

  • Letter
  • Multicenter Study
  • Observational Study

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Continuous Positive Airway Pressure* / instrumentation
  • Continuous Positive Airway Pressure* / methods
  • Continuous Positive Airway Pressure* / standards
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / physiopathology
  • Coronavirus Infections* / therapy
  • Equipment Design
  • Female
  • Head Protective Devices*
  • Humans
  • Hypoxia* / etiology
  • Hypoxia* / therapy
  • Infection Control / instrumentation
  • Infection Control / methods
  • Italy
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care
  • Oximetry / methods
  • Pandemics*
  • Pneumonia, Viral* / blood
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / etiology
  • Pneumonia, Viral* / physiopathology
  • Pneumonia, Viral* / therapy
  • Quality Improvement
  • Respiratory Function Tests / methods
  • SARS-CoV-2